Results 181 to 190 of about 115,135 (343)

Posttranslationally modified self-peptides promote hypertension in mouse models

open access: yesThe Journal of Clinical Investigation
Posttranslational modifications can enhance immunogenicity of self-proteins. In several conditions, including hypertension, systemic lupus erythematosus, and heart failure, isolevuglandins (IsoLGs) are formed by lipid peroxidation and covalently bond ...
Nathaniel Bloodworth   +13 more
doaj   +1 more source

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation [PDF]

open access: gold, 2017
Marek Wieczorek   +6 more
openalex   +1 more source

Multi‐omics profiling identified two epithelioid sarcoma molecular subtypes with distinct signaling and immune characteristics

open access: yes
Cancer Communications, EarlyView.
Carine Ngo   +30 more
wiley   +1 more source

CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling

open access: yesMed Research, EarlyView.
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li   +8 more
wiley   +1 more source

Parkinson's‐Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa

open access: yesMovement Disorders, EarlyView.
Abstract Background Peripheral disease mechanisms such as immune dysregulation may contribute to Parkinson's disease (PD). To investigate interactions between common PD mutations and immune responses to environmental pathogens, we studied responses to Pseudomonas aeruginosa (P.
Julian R. Mark   +8 more
wiley   +1 more source

Biological mechanism and immune response of MHC-II expression in tumor cells. [PDF]

open access: yesCancer Biol Med
Zhou M, Pan S, Zhang Y, Hu C, Xu Z.
europepmc   +1 more source

Home - About - Disclaimer - Privacy